Healthy Volunteer Study Clinical Trial
Official title:
A Study to Evaluate the Impact of Activated Charcoal on the Absorption of LY2140023 in Healthy Subjects
The study will evaluate the effect of activated charcoal on absorption of LY2140023. The study involves a single dose of 80 milligrams (mg) LY2140023 taken as 1 tablet by mouth 2 times during study (once with activated charcoal, once without activated charcoal). This study will last approximately 16 days, not including screening. Screening is required within 28 days prior to study entry.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03270878 -
Glasdegib Absolute Bioavailability Study
|
Phase 1 | |
Completed |
NCT03777488 -
Pharmacokinetics of Tranexamic Acid After Oral, Intramuscular or Intravenous Administration: a Prospective, Randomised, Cross-over Trial in Healthy Volunteers.
|
Phase 1 | |
Completed |
NCT03086278 -
A Study of AST-008 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04711187 -
Study of AT-527 in Healthy Subjects (R07496998)
|
Phase 1 | |
Completed |
NCT06141889 -
Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05154123 -
Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)
|
Phase 1 | |
Completed |
NCT05179421 -
Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain
|
Phase 2 | |
Completed |
NCT03945344 -
Effect of Charcoal on Gastrointestinal Absorption of Tiotropium
|
Phase 1 | |
Recruiting |
NCT05881993 -
Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects
|
Early Phase 1 | |
Completed |
NCT04242953 -
Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects
|
Phase 1 | |
Completed |
NCT02393950 -
Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00866385 -
AZD8566 Food Effect/Microtracer Study
|
Phase 1 | |
Completed |
NCT04784000 -
Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527
|
Phase 1 | |
Completed |
NCT02503085 -
Ibuprofen Suspension Bioequivalence Study
|
Phase 1 | |
Completed |
NCT05004415 -
Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)
|
Phase 1 | |
Completed |
NCT02256423 -
A Study Comparing Three Formulations of Ibuprofen in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01425450 -
Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05731843 -
Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir
|
Phase 1 | |
Completed |
NCT03031535 -
Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers
|
Phase 1 | |
Completed |
NCT02452450 -
Ibuprofen and Paracetamol Pharmacokinetic Study
|
Phase 1 |